Venneker G T, van Meegen M, de Kok-Nazaruk M, Hulsmans R F, de Waall L P, Bos J D, Asghar S S
Department of Dermatology, University of Amsterdam, The Netherlands.
Exp Clin Immunogenet. 1996;13(2):104-11.
In a previous study, a patient suffering from linear frontoparietal scleroderma and some of his family members were found to have an incomplete functional deficiency of the second component (C2) of complement (C). In this study, the proband and the rest of his family members were investigated for functional deficiencies of C2 and the fourth component of C (C4). A search for null alleles of C2 (C2Q0) and C4 (C4Q0) was made to find out whether their occurrence is responsible for incomplete functional deficiencies. HLA analysis was performed to find out whether deficiencies are linked to HLA alleles known to be associated with C4Q0 and C2Q0. Possible large deletions at C4 and 21-hydroxylase (21-OH) gene loci were also investigated in some family members.
The proband had a combined functional deficiency of C4 and C2. Some of his family members had a partial functional deficiency of C4, some of C2 and some of C4 and C2; none had null alleles of C2 (C2Q0), factor B (BQ0) or C4B (C4BQ0). C4Q0 or functional C4 deficiency in this family was not associated with HLA-A1;B8;DR3 alleles. C2 deficiency was also not associated with HLA antigens known to be associated with type I and II C2 deficiencies. No gene deletion or unusual polymorphism at C4A and 21-OHA loci could be seen by restriction fragment length polymorphism (RFLP) studies.
Combined and isolated partial functional deficiencies of C4 and C2 observed in the proband and many of his family members were not caused by C activation or null alleles. They were not linked to HLA system and were reminiscent of those observed previously in a family in which C4 deficiency was determined by a gene not linked to the HLA system.
在之前的一项研究中,发现一名患有线性额顶叶硬皮病的患者及其部分家庭成员存在补体(C)第二成分(C2)的不完全功能缺陷。在本研究中,对先证者及其其他家庭成员进行了C2和C第四成分(C4)的功能缺陷调查。搜索C2(C2Q0)和C4(C4Q0)的无效等位基因,以确定它们的出现是否导致不完全功能缺陷。进行HLA分析,以确定缺陷是否与已知与C4Q0和C2Q0相关的HLA等位基因有关。还对一些家庭成员的C4和21-羟化酶(21-OH)基因位点可能存在的大片段缺失进行了研究。
先证者存在C4和C2的联合功能缺陷。他的一些家庭成员存在C4的部分功能缺陷、C2的部分功能缺陷以及C4和C2的部分功能缺陷;没有人具有C2(C2Q0)、B因子(BQ0)或C4B(C4BQ0)的无效等位基因。该家族中的C4Q0或功能性C4缺陷与HLA-A1;B8;DR3等位基因无关。C2缺陷也与已知与I型和II型C2缺陷相关的HLA抗原无关。通过限制性片段长度多态性(RFLP)研究,未发现C4A和21-OHA基因位点存在基因缺失或异常多态性。
先证者及其许多家庭成员中观察到的C4和C2联合及孤立的部分功能缺陷并非由C激活或无效等位基因引起。它们与HLA系统无关,这让人想起之前在一个家族中观察到的情况,该家族中C4缺陷由一个与HLA系统无关的基因决定。